This document provides an in-depth overview of epilepsy in dogs and cats. It defines seizures, describes different seizure types including focal and generalized seizures. It discusses causes of seizures including idiopathic epilepsy which has a genetic basis in some breeds, structural epilepsy caused by brain abnormalities, and reactive seizures triggered by systemic issues. The document outlines testing, treatment including common anti-seizure medications like phenobarbital, and conditions that can mimic seizures.
Peripheral neuropathy (PN) is damage to or disease affecting nerves, which may impair sensation, movement, gland or organ function, or other aspects of health, depending on the type of nerve affected
Peripheral neuropathy (PN) is damage to or disease affecting nerves, which may impair sensation, movement, gland or organ function, or other aspects of health, depending on the type of nerve affected
Pharmacotherapy of Alzheimer's disease
Introduction
History
Risk factors
Pathophysiology
Symptoms
Diagnosis
Non pharmacological treatment
Drugs used in treatment of Alzheimer`s
Recent advances
Screening methods
Summary
References
Alzheimer's is the most common form of dementia, a general term for memory loss and other intellectual abilities serious enough to interfere with daily life. Alzheimer's disease accounts for 60 to 80 percent of dementia cases.
Guillain-Barré syndrome is a rare but serious autoimmune disorder in which the immune system attacks healthy nerve cells in your peripheral nervous system (PNS).
Pharmacotherapy of Alzheimer's disease
Introduction
History
Risk factors
Pathophysiology
Symptoms
Diagnosis
Non pharmacological treatment
Drugs used in treatment of Alzheimer`s
Recent advances
Screening methods
Summary
References
Alzheimer's is the most common form of dementia, a general term for memory loss and other intellectual abilities serious enough to interfere with daily life. Alzheimer's disease accounts for 60 to 80 percent of dementia cases.
Guillain-Barré syndrome is a rare but serious autoimmune disorder in which the immune system attacks healthy nerve cells in your peripheral nervous system (PNS).
"Maintaining Sterility During a Surgical Procedure"upstatevet
"Maintaining Sterility During a Surgical Procedure: How to Create and Maintain a Sterile Surgical Field" Ashley Braman, LVT and Brittany Weeden, LVT, September 17, 2016
It contains description and salient points to diagnose various epileptic encephalopathies seen during infancy such as early myoclonic encephalopathies, Otahara syndrome, Dravet syndrome, West syndrome.
Title: Cardiac Emergencies of the Dog and Cat
Presented by: Agnieszka Kent, DVM, MS, DACVIM (Cardiology)
Description: This course will discuss common cardiac emergencies and how to identify and determine the primary problem through effective history-taking, physical examination, and diagnostics. We will discuss how to approach each emergent condition with treatment strategies and monitoring to help you be as successful as possible in helping your patients through these life-threatening conditions.
Uh-oh ... It Went Neuro: Triaging the Acute Neurologic Patientupstatevet
Title: Uh-oh ... It Went Neuro: Triaging the Acute Neurologic Patient
Presented by: Todd Bishop, DVM, DACVIM (Neurology)
Description: This lecture is geared toward primary care veterinarians and will cover recognizing the three most common neurologic emergencies, triaging the severity, and performing an initial neurologic evaluation. The lecture will include initiating a minimum database and basic diagnostic work-up, providing first responder-type therapeutic interventions, and knowing if/when to refer.
Itching, Scratching, Atopy Oh My! Diagnosis and Treatment of the Allergic Pat...upstatevet
Title: Itching, Scratching, Atopy Oh My! Diagnosis and Treatment of the Allergic Patient
Presented by: Amy Schnedeker, DVM, MS, DACVD
Description: This course aims to discuss the work-up of allergy patients, starting from diagnostics and treatment of secondary infections to different medications for managing pruritus and diagnosing underlying allergic diseases - flea allergy versus food allergy versus atopic dermatitis.
Radiographic Positioning and Quality Control of Thoracic, Abdominal, and Orth...upstatevet
Title: Radiographic Positioning and Quality Control of Thoracic, Abdominal, and Orthopedic Studies
Presented by: Amanda Breyette, LVT, BT, FFCP & Adam Isack, LVT, FFCP
Description: Radiographs that are positioned correctly with proper technique give a better representation of anatomy and disease processes. This, in turn, gives the patient a better chance of being treated appropriately. Throughout this course, you will learn the anatomy to be included in each study, proper/improper technique, and how to correct misaligned radiographs.
Pain Management – A Review and What's Newupstatevet
Title: Pain Management – A Review and What's New
Presented by: Mylissa Fitzpatrick, LVT, CCVP, VTS (Emergency)
Description: This pain management course is designed for veterinary technicians wishing to broaden their education on integral pain management options. The lecture will cover patient pain identification, pharmaceutical pain management options, non-pharmaceutical therapies, and alternative modalities. New pain management drugs and their applications will also be discussed.
Title: Diagnostics in Veterinary Oncology
Presented by: Ariana Verrilli, DVM, DACVIM (Oncology)
Description: This session will discuss the various tests currently available in veterinary oncology, from cytology and histopathology to DNA sequencing and genetic testing. We will review the pros and cons of multiple tests, the best use for each test, and how to interpret results. We will also review sample submissions and specific lab requirements as appropriate.
Leptospirosis in Dogs: What's Bloodwork Got to Do with It?upstatevet
Title: Leptospirosis in Dogs: What's Bloodwork Got to Do with It?
Presented by: Ciera Earl, LVT, VTS (Emergency)
Description: Leptospirosis is a common zoonotic disease that can cause serious illness in dogs, other wild animals, and people. Throughout this lecture, we will look at common lab work and provide a better understanding of the values, their meaning, and how it all ties together in diagnosing Leptospirosis. We will also discuss the signs and symptoms, transmission, prevalence, and treatment.
Cortisol: Friend or Foe, An Overview of Cushing's Disease and Addison's Diseaseupstatevet
Title: Cortisol: Friend or Foe, An Overview of Cushing's Disease and Addison's Disease
Presented By: Erica Hunt, LVT, VTS
Description: This lecture will review the physiology of Cushing's and Addison's disease so that the technician can better understand the disease processes. We will also discuss different treatment options and the necessary monitoring.
Presenter: Dr. Madeline Frazier, DVM, DACVECC
Title: Shock and Paw
Description:
What does it mean when we ask, “Is the patient stable?” Identifying shock quickly and accurately is critical for optimizing patient outcome. This lecture will review broad definitions for shock, the types of shock and their pathophysiology, and how to identify the different types of shock (including occult shock). The lecture will also provide guidelines for treatment of the different shock states, as well as modalities of fluid resuscitation.
Presenter: Dr. Christina Scanlon, DVM, DACVIM (Neurology)
Title: Alphabet Soup Myelopathies
Description:
This course will cover signalment, clinical signs, confirmatory diagnostics, and therapies for myelopathic diseases different from the most common IVDD cases. This lecture will help you recognize cases that are more likely to be FCE or ANNPE based on presentation and will discuss recommended testing, prognoses, and therapies. The presentation will also cover one case of a slightly different myelopathy that is less commonly seen overall.
Learning Objectives:
- To be able to recognize clinical signs and signalment for FCE and ANNPE
- To understand imaging characteristics and differences between FCE and ANNPE
- To understand prognostic indicators and recommended therapies for FCE and ANNPE
Presenter: Dr. Andrew Waxman, DVM, DACVIM (Cardiology)
Hosted by Upstate Veterinary Specialties
Session Description:
Congenital heart diseases are abnormalities of the cardiovascular system which are present at birth. The exact underlying factors are not always understood but are suspected of genetic origin in dogs and cats. Some of the most common diseases include patent ductus arteriosus, pulmonic stenosis, subaortic stenosis, tricuspid valve dysplasia, and ventricular septal defects. These conditions can vary from innocent to life-threatening. This lecture will help participants understand the examination findings, the most common treatment options (if available), and breeding considerations regarding congenital heart disease in dogs and cats. There will also be some discussion about innocent murmurs in young patients.
Introducing Diagnostic Ultrasound in General Practiceupstatevet
Chris Ryan, DVM, DACVR
This lecture will begin by reviewing the basic operation of ultrasound equipment with a focus on hardware and software features common to almost all machines. The various settings and controls will be reviewed, along with the effects that these have on overall image quality, and how to utilize these settings to optimize image quality. A roadmap will then be developed for applying ultrasound in everyday general practice, beginning with the basics of evaluation for abdominal or pleural cavity fluid, and proceeding to perform a complete basic abdominal ultrasound exam. Normal sonographic anatomy and measurements will be reviewed, along with a recommended acquisition protocol for submission to teleradiology services.
Tips and Practical Solutions to Dental Challengesupstatevet
Thomas Phillips, DVM, Fellow of the Academy of Veterinary Dentistry 2007
All veterinarians face challenging dental cases. This course will offer options and techniques to successfully accomplish difficult extractions, oronasal fistula, and tips and tricks for dental procedures.
Diagnosing and Treating Canine Incontinence and Urolithsupstatevet
Alison Khoo, BSc, BVMS, DACVIM (Internal Medicine)
Urinary incontinence is a common presenting complaint in veterinary practice. Treatment of refractory cases may become a major source of frustration for both owners and veterinarians. Medical, surgical, and interventional therapeutic options will be discussed.
Respiratory Distress in the Small Animal Patientupstatevet
Danielle Berube, DVM, DACVECC
This presentation will review the many differentials for patients presenting in respiratory distress. The lecture will be organized based on anatomic locations within the airway, including upper airway disorders, pulmonary causes of respiratory distress, and diseases of the pleural space. Within each section, we will focus on the physical examination findings, diagnostic options to localize the disorder, and stabilization techniques for the patient. We will also discuss less common causes of respiratory distress such as acute lung injury (ALI), acute respiratory distress syndrome (ARDS), transfusion related acute lung injury (TRALI) and even some examples of nonrespiratory look-alikes.
An Overview of Lymphoma for the Veterinary Technicianupstatevet
Theresa Kilichowski, LVT, Oncology
Lymphoma is one of the most commonly diagnosed cancers in veterinary practice. This course will teach the technician lymphoma subtypes and survival times, treatment options, side effects, and quality of life goals. This course will help technicians confidently provide support and education to their pet owners after a diagnosis of lymphoma.
Erica Zappia, LVT, Internal Medicine
This course will review vital information for the veterinary technician regarding the diagnosis and management of diabetes mellitus. Participants will learn physiology, clinical signs, and laboratory abnormalities of diabetes. Important communication practices between the veterinary technician and the client will be discussed.
Assessment and Treatment of Pain in the Emergency and Critical Care Patientupstatevet
Abby Luvera, LVT, Emergency
This lecture will discuss the importance of treating acute pain in our emergency and critical care patients, with an emphasis on the role of the veterinary technician in the recognition, assessment, and treatment of pain. Participants will learn sources of acute pain and available treatment modalities, as well as common pitfalls and challenges when assessing pain. Participants will also hear options for implementing a pain scoring system for their practice and resources for continued education.
Pattern Recognition and the ECG – Clinical Interpretation for the LVT upstatevet
Aaron Wey, DVM, DACVIM (Cardiology)
This lecture will be useful for both new and experienced LVTs and will review the clinical ECG as used in small animal practice. Lecture topics will begin with suggestions for obtaining a good quality ECG and will finish with recognition of common rhythm abnormalities encountered in companion animal practice. Audience participation will enhance the lecture and allow attendees to test their knowledge acquired during the presentation.
Joe Palamara, DVM, DACVS-SA
Description: Dyspnea is defined as difficulty/labored breathing or shortness of breath, and can be a sign of serious disease of the airway, lungs or heart. This lecture will review the process of diagnosing, stabilizing and further localizing dyspnea in dogs. We will discuss recommendations for surgical correction of components of Brachycephalic Airway Syndrome, as well as salvage procedure for Laryngeal paralysis. With appropriate management, the prognosis for these conditions is generally favorable depending on the degree of severity.
Learning Objectives
- Recognize the clinical signs, associated physiology, and diagnosis related to each condition
- Initial stabilization for patients presenting in airway crisis
- Understand the medical and surgical options for each condition
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
3. Seizures
Seizures are the most common neurologic problem
in small-animal medicine
Incidence of idiopathic epilepsy is between 0.5% -
5%
Some breeds have much higher incidence
Treatment dependent on underlying cause
4. What causes a seizure?
An epileptic seizure: clinical manifestation of
excessive and/or hypersynchronous electrical activity
in the cortex
Altered excitability of a group of neurons can lead to
marked and prolonged depolarization
Can involve neurons in a specific region of the brain
focal seizure
Entire cerebrum
generalized seizure
http://vanat.cvm.umn.edu/brainAtlas/
5.
6. Pathophysiology
Inadequate neuronal inhibition—major inhibitory
NTs include GABA and glycine
Excessive neuronal excitation—major excitatory NTs
include aspartate and glutamate
A combination of 1 & 2
http://thebark.com/content/vet-advice-seizures-dogs-and-canine-epilepsy
7. Resting membrane potential is normally set so
neurons are not constantly firing
Close enough to threshold that they can discharge
AP generation is essential to CNS function
The control of resting potential is critical to prevent
excessive discharge associated with seizures
https://primalcanine.wordpress.com/tag/infographic/
8. Normally a high [K+] inside a neuron and there is a
high EC [Na+]
If the balance is upset (e.g. if K+ is elevated in the EC
space), this can lead to depolarization that promotes
abnormal activity
9. Primary generalized seizures
The initial clinical signs reflect involvement of both
hemispheres
Impairment of consciousness is common
Motor manifestations are bilateral
Generalized tonic-clonic seizures are the most
common
http://www.labrador-retriever-pet.com/seizures-in-dogs.html
10. Seizure classification
Generalized tonic-clonic seizures
The 1st part of the seizure = tonic phase
sustained contraction of all muscles
Loss of consciousness and falling
Breathing
irregular or absent, and cyanosis
Salivation, urination, or defecation
The tonic phase lasts for ~1 min and leads to clonic
phase
paddling or rhythmic jerking of the limbs and chewing
movements
The clonic phase is usually < 1-2 min
Consciousness can be maintained
12. Seizure classification
Tonic seizures
Consists of generalized muscle rigidity w/o clonus
Clonic seizures
Paddling and jerking with no tonic component
Atonic seizures
Sudden, often brief losses of muscle tone
May be a brief drop of the head, or sudden collapse
13. Seizure classification
Myoclonic seizures
Brief contractions that may be generalized or confined
to individual muscle groups
Not all myoclonic jerks are seizures
Absence seizures
In people defined as abrupt, brief losses of
consciousness
Not recognized in vet med
Characterized by brief episodes of unresponsiveness,
sometimes w/ facial twitching & mild limb jerking
14. Types of seizures: focal
Initial clinical signs indicate abnormal activity in
one region of a cerebral hemisphere
Simple focal seizures do not impair consciousness
When consciousness is impaired classified as
complex focal
Motor signs, autonomic signs, and behavior signs
are most common
15. Focal seizures
Focal seizures with motor signs
Rhythmic contractions of facial or masticatory
muscles, abnormal movements of one limb, and
turning the head to one side
Focal seizures with autonomic signs
Autonomic signs include hypersalivation, vomiting,
gagging, diarrhea, and apparent abdominal pain
16. Focal seizures
Focal seizures with abnormal behaviour
In people can cause sensory symptoms: e.g. abnormal
skin or vision sensations
Seizures manifested as licking or chewing and “fly-
biting” may be similar
Complex focal seizures may be manifested as impaired
consciousness and bizarre behaviour, e.g. aggression
or extreme, irrational fear
http://www.vetneurochesapeake.com/index.php?
page=questions-about-dog-seizures
19. Stages of a seizure
Prodrome
A long-term indication of a forthcoming seizure
May exhibit abnormal behaviour
restlessness, clinginess, and vocalizing (hours to days
before a seizure)
Not always seen
20. Aura
The initial sensation of a seizure before observable signs
Last seconds to minutes
Initial abnormal electrical activity in the brain
Hide, clinginess, agitation
Difference between a prodrome and an aura is that
prodromes are longer and not associated with abnormal
EEG
Auras are short and caused by abnormal EEG
www.canine-epilepsy.net
21. Ictus
The seizure itself
Postictal stage
Transient abnormalities in brain
function that are caused by the ictus
and appear when the ictus has ended
Disorientation, restlessness, ataxia,
blindness, and deafness
Often resolve after several mins, but
may last for days
http://blogs.biomedcentral.com/bmcseriesblog/2014/10/22/
bmc-veterinary-research-authors-discuss-how-poor-study-design-
inhibits-progress/
22. Reactive Seizures
Reactive seizures are the reaction of a normal brain
to a systemic problem
Metabolic
Nutritional
Toxic disorder
25. Structural Epilepsy
Caused by a known and identifiable structural
forebrain disorder
vascular, inflammatory, traumatic, anomalous/
developmental, neoplastic and degenerative diseases
Reported prevalence of structural epilepsy in dogs
and cats varies
25–38% in dogs
34–87% in cats
27. From A Practical guide to canine and feline neurology 2nd Ed
28.
29. Idiopathic epilepsy
Recurrent seizures and no identifiable brain
abnormality
May have a genetic basis
Normal interictal exam
Diagnosis of exclusion
Signalment
Onset: 1st seizure between 6 mos and 6 yrs
http://newsnetwork.mayoclinic.org/discussion/epilepsy-symptoms-
causes-complications-and-what-you-can-do/
30. Genetic basis in some breeds
Prevalence of epilepsy in certain breeds of dog has
been documented to be much higher than the
estimated 0.5 to 6% in the general population
Belgian shepherd Tervueren and Groenendael
variants: prevalence estimated in one study to be
9.5%, and as high as 33% in one extended Belgian
shepherd family (Berendt et al., 2008, 2009)
Prevalence of 18.3% was documented in Irish
wolfhounds with IE
Study of Petit Basset Griffon Vendeen dogs with IE
revealed a prevalence of 8.9% (Casal et al., 2006; Gullov et al.,
2011).
32. Lifespan and epilepsy
MST after the initial seizure is 2.07 yrs in Border
collies and 2.3 years in a population of different
purebred and mixed-breed dogs (Proschowsky et al., 2003;
Berendt et al., 2007; Hulsmeyer et al., 2010)
The life expectancy for Irish wolfhounds is
shortened by ~2 yrs in IE dogs compared with
seizure-free relatives
> 60% of the total number of deaths in the
population were related to epilepsy (Casal et al., 2006)
33. Lifespan and epilepsy
Study of survival in Belgian shepherds with IE
showed that the lifespan of epileptic dogs was not
significantly shortened by the presence of epilepsy
Epilepsy was the predominant cause of death in the
population (Gullov et al., 2012)
34.
35. Feline seizures
The prevalence of feline seizures has been reported
as 2.1-14%
http://pets.thenest.com/tremors-seizures-cats-8114.html
38. Disorders mistaken for
seizures
Syncope is characterized by partial or complete
loss of consciousness, lack of violent motor
activity, short duration and lack of post-ictal signs
Often associated with exercise and caused by
cardiac or respiratory disease
39.
40. Disorders mistaken for
seizures
Narcolepsy is usually manifested as episodes of
flaccid paralysis or loss of consciousness
precipitated by excitement such as feeding,
greeting, or play
http://www.tomopop.com/dog-narcolepsy-the-growing-epidemic-11787.phtml
42. Disorders mistaken for
seizures
Myasthenia gravis can cause stiffness, tremor, or
weakness with normal consciousness
Clinical signs of MG may be induced by exercise
Some myopathies can cause similar clinical signs
44. Disorders mistaken for
seizures
Peripheral vestibular dysfunction is characterized
by ataxia, head tilt, and abnormal nystagmus with
no impairment of consciousness.
47. Disorders mistaken for
seizures
Episodes of encephalopathy can cause
disorientation, ataxia, blindness, and abnormal
behavior
E.g Hepatic encephalopathy
48. Disorders mistaken for
seizures
Normal or abnormal movements during sleep
consist of twitching, paddling, or vocalizing while
the patient is asleep
Waking the animal can interrupt these, and there
are no postictal signs
49. Disorders mistaken for
seizures
Behavior disorders, such as stereotypy, can cause
specific patterns of unusual behavior
These episodes can usually be interrupted, and
there are no postictal signs.
50. Disorders mistaken for
seizures
Pain, especially neck pain, can cause episodes of
muscle rigidity or stiffness and crying
Consciousness is not impaired
53. Testing
A CBC/chem to screen for metabolic causes of
seizures (e.g. hypoglycemia)
Serum BAs are tested in young animals to identify
PSS
Blood lead with hx of possible exposure
Thyroid function is evaluated in adult dogs
hypothyroidism may complicate seizures and
phenobarbital can affect thyroid testing
54. Testing
MRI +/- CSF are indicated in dogs with:
interictal neurologic deficits
seizures refractory to therapy
onset of seizures <1 year or >5 years of age
any cat with seizures
Patients with IE often have normal MRIs, transient MRI
brain lesions secondary to seizure activity are
occasionally seen
These lesions tend to be hyperintense on T2, do not
distort surrounding brain parenchyma, and tend to occur
in several brain regions (e.g., pyriform, temporal, and
frontal lobes, and the hippocampus)
55. Therapy
The goal of tx is to the frequency and severity of
the seizures
QOL (pet and family)
Tx: seizures vs mimic
Therapeutic trial: seizure vs movement disorder
www.pinterest.com
56. When to start therapy?
≥ 2 seizures in 2-3 mo
SE or cluster seizures
Post-ictal behaviour
Intracranial dz, trauma
66. Phenobarbital
The elimination t½ is 40-90 hr in the dog and
~40-50 hr in the cat after PO admin
10-15 days needed to reach steady-state
Potent inducer of hepatic microsomal enzyme
activity and can lead to accelerated administration
of itself as well as other hepatically metabolized
drugs.
68. Phenobarbital
The initial dose is 3-5 mg/kg orally q 12 hr in dogs
Similar range in cats
Lower initial dose of 2.5 mg/kg orally q 12 hr
http://www.actavis.com.mt/en/products/Phenobarbital+-+Actavis.htm
69. Phenobarbital
Serum levels should be checked 2 wks after
initiating therapy or changing the dose
The target range is 20-30 ug/ml
There is no clinically significant impact of the
timing of blood collection (e.g trough versus peak
level) in most dogs
70. Zonisamide
ZNS is metabolized primarily by hepatic
microsomal enzymes and the t½ of elimination in
dogs is ~ 15 h
The elimination t½ of ZNS is shorter in patients
already receiving drugs that stimulate hepatic
microsomal enzymes (e.g. phenobarbital)
http://www.heartlandvetsupply.com/
p-4681-zonisamide-capsules.aspx
72. Zonisamide
When used as add-on therapy for dogs already
receiving phenobarbital, the recommended dose
regimen is 10 mg/kg PO q12 hr
Has been shown to maintain canine serum [ZNS]
within the therapeutic range when used as add-on
therapy
For dogs not receiving phenobarbital, it is
recommended to start at 5 mg/kg PO q12 hr
Check trough serum ZNS concentrations after ~2
wks
73. Bromide
Administered as KBr or NaBr
KBr is preferred when Na+ intake must be
restricted (for example, CHF)
NaBr is preferred when K+ intake must be
restricted (for example, hypoadrenocorticism)
http://www.petdoctorsofamerica.com/
pharmacy/index.php/k-brovet-potassium-
bromide-rx-required.html
75. Bromide
The elimination t½ is 24 d in dogs, 11 d in cats
It takes ~ 80-120 days to reach steady-state
kinetics in dogs, 6 weeks in cats
The initial maintenance dose for KBr is 20-35 mg/
kg, PO SID, or divided BID
If NaBr is used, the dose should be decreased by
15% (i.e., 17-30 mg/kg) to account for the higher
bromide content of the Na salt
76. KBr Loading
24-hour loading dose
(1) A total dose of 400-600 mg/kg of KBr is
administered PO over 24 hours
(2) This is divided into doses of 100 mg/kg (the lower
end of the range) q 6 hr, for a total of 4 doses
(3) If the patient appears obtunded prior to a dose,
skip it and resume when the patient is alert again
(4) After loading, begin the regular dose the next day
(5) This schedule is used in patients that need
adequate seizure protection immediately
(6) The patient should be hospitalized for this loading
procedure
77. KBr Loading
5 d loading dose
(1) Administer 450 mg/kg of potassium
bromide over 5 days
(2) The daily loading dose (90 mg/kg) is added
to the maintenance daily dose (35 mg/kg) for a
total PO dose for each of the 5 days of 125 mg/
kg/day. This dose should be divided BID to
avoid GI irritation
(3) On day 6, the maintenance dose is started
78. Bromide
A serum bromide level is checked within 1 week
after loading or 3 months after starting a
maintenance dose
Timing of sample collection is unimportant
because of the long half-life
The target range is 1-3 mg/ml for patients taking
bromide alone
1-2 mg/ml for those taking bromide and
phenobarbital
79. Bromide
Bromide competes with chloride for renal
elimination
High chloride intake increases bromide elimination,
which increases the dose requirement
The chloride content of the diet should not be
drastically altered during treatment
80. Levetiracetam (Keppra)
The t½ of elimination for levetiracetam in dogs is
~4 hours
Drug is nearly 100% bioavailable following PO
dose
~70%-90% of the drug is eliminated unchanged
in the urine, the remainder being hydrolyzed in
the serum and other organs
There is no hepatic metabolism of
levetiracetam, and it is very safe in dogs
82. Administered IV, can be administered IM
IV administration is good in ER situations
20-30 mg/kg, PO q8 hours
83. Gabapentin
Despite undergoing some hepatic metabolism in
dogs, there does not appear to be any appreciable
induction of hepatic microsomal enzymes in this
species
The elimination t½ for gabapentin in dogs is 3-4
hours
http://www.gaba-supplement.com/
84. Gabapentin
Initial dose regimen of 10 mg/kg body weight q 8 hr,
titrate
Side effects appear to be uncommon and are
typically limited to mild sedation, pelvic limb ataxia,
and increased appetite with attendant weight gain
85. Pregabalin
Canine dosage of 2-4 mg/kg body weight, q 8 hrs
Dosing should start at the low end (2 mg/kg) and
be increased weekly, as needed, in order to avoid
obvious side effects (e.g., sedation, ataxia).
http://www.searchhomeremedy.com/
drugs-and-medications-to-treat-
fibromyalgia/
87. Diazepam
Benzodiazepines are believed to exert anticonvulsant
activity by enhancing GABA effects in the brain
Benzodiazepines are metabolized primarily by the
liver
The short t½ of diazepam in dogs (2-4 hours) and
development of tolerance limits the use of this drug
for maintenance therapy
Diazepam is used in dogs and cats IV or rectally for
emergency treatment of seizures
Fatal hepatic necrosis has been associated with oral
diazepam in cats
92. Therapeutic Monitoring
After starting treatment
Dose change
Loading dose
Poor seizure control
Dose-related toxicity occur, to determine if a
dose decrease is necessary
Every 6-12 months to verify that changes in
pharmacokinetics or compliance have not
caused change in concentration
94. Cluster Seizures
Cluster seizures (serial seizures, acute repetitive
seizures)
≥ 2 seizures occurring over a brief period with normal
consciousness between events
Occurrence of > 3 seizures in 24 hrs should be
considered an emergency
May evolve into SE and should be treated
Study of 407 dogs with IE found that 41% had CS
at least once during their seizure history (Monteiro et al.,
2012)
A study in Border collies with confirmed IE revealed
that CS occurred in 94% of the cases and SE in
53% (Hulsmeyer et al., 2010)
95. Cluster seizures
48% of Australian shepherd dogs diagnosed with IE
< 5 years of age had both CS and SE, 12% SE only
and 20% CS only (Weissl et al., 2012)
One study with 125 cats having primary and
secondary causes of seizure activity found CS in
53% and 59% of cases, respectively (Pakozdy et al., 2010)
96. Status epilepticus
Continuous seizure ≥ 5 minutes or ≥ 2 discrete
seizures w/o full recovery of consciousness
between
Relatively frequent among dogs with IE, can
occur with seizure disorders of any etiology
~59% of dogs with epilepsy of any cause will
have one or more episodes of SE during their
life (Saito et al., 2001)
Large breed dogs are at increased risk
Status is a life-threatening emergency
97. Status epilepticus
Seizure activity >30 minutes may cause systemic
dysfunction, including hypoxia, altered BP, and
hyperthermia and can lead to temporary or
permanent brain lesions
The most common type of SE is generalized tonic-
clonic status
With a prolonged seizure, the clinical manifestations
can eventually become subtle, with only altered
mentation and small twitching movements of the
face or limbs.
“electromechanical disassociation” and should be
treated
99. ER treatment of seizures
− O2
− Stat: BG, PCV/TS, lactate, platelet count,
BUN / crea, ECG, thoracic radiographs
− Obtain blood sample for CBC/chem, UA,
[AED], sampling for toxicology and
infectious disease titers
− IVF
100. ER treatment
− Administer dextrose-IV bolus (1 to 5ml 50%
dextrose) ONLY in documented hypoglycemia
− Hyperthermia should be rapidly corrected
− Acidosis does not usually necessitate treatment
− Marked metabolic acidosis often resolves w/
stabilization
− Respiratory acidosis needs immediate treatment
101. Treatment
Initiate AED to stop all gross motor seizure activity
or to rapidly reach therapeutic serum levels in the
non seizuring dog
Diazepam (DZ) IV bolus 0.5 mg/kg
Wait 5 minutes for effect / repeat
Rectal DZ: reserved for patients where IV access
cannot be obtained / out-of-hospital treatment
TREAT EARLY
Administer diazepam at 0.5-1.0 mg/kg, IV. Repeat for a
total of 3 doses as necessary to stop the seizure
The duration of anti seizure effects is 30 min or less, so a
longer-lasting AED drug should also be given